Antidepressant usage in the Canadian Forces

Military Medicine

Volumn 171, Issue 2, 2006, Pages 107-111

  Gutschi, L Maria ^a   Vaillancourt, Régis ^a,b   Boddam, Randy ^b  

^a Patented Med Prices Review Board   (Canada)

^b Canadian Forces Health Services   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARMY; CANADA; CONTROLLED STUDY; DEPRESSION; DRUG INDICATION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; RETROSPECTIVE STUDY; REVIEW; SOLDIER;

EID: 32144459974     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.171.2.107     Document Type: Review

References (25)

1. Hemels ME, Koren G, Einarson TR: Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother 2002; 36: 1375-9.
2. Patten SB: Progress against major depression in Canada. Can J Psychiatry 2002; 47: 775-80.
3. Johnson RE, McFarland BH, Nichols GA: Changing patterns of antidepressant use and costs in a health maintenance organisation. Pharmacoeconomics 1997; 11: 274-86.
4. Isacsson G, Boethius G, Henriksson S, Jones JK, Bergman U: Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations: findings from a Swedish prescription database. J Affect Disord 1999; 53: 15-22.
5. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA: National trends in the outpatient treatment of depression. JAMA 2002; 287: 203-9.
6. Murray CJL, Lopez AD: Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Disease, Injuries, and Risk Factors in 1990 and Projected to 2020, Boston, MA, Harvard School of Public Health, 1996.
7. Parikh SV, Lesage AD, Kennedy SH, Goering PN: Depression in Ontario: undertreatment and factors related to antidepressant use. J Affect Disord 1999; 52: 67-76.
8. Federal, Provincial, and Territorial Advisory Committee on Population Health: Statistical Report on the Health of Canadians. Ottawa, Canada, Health Canada, 2000.
9. Statistics Canada: Canadian Community Health Survey Supplement 2002, Available at http://hr.ottawa-hull.mil.ca/health/information/op_health/ stats_can/ engraph/StatsCan_home_e.asp?Lev1=2&Lev2=13&Lev3=2.
10. Hunter CL, Hunter CM, West ET, Kinder MH, Carrol DW: Recognition of depressive disorders by primary care providers in a military medical setting. Milit Med 2002; 167: 308-11.
11. Hoge CW, Lesikar SE, Guevara R, et al: Mental disorders among U.S. military personnel in the 1990s: association with high levels of health care utilization and early military attrition. Am J Psychiatry 2002; 159: 1576-83.
12. Canadian Network for Mood and Anxiety Treatments: Guidelines for the Diagnosis and Pharmacological Treatment of Depression, Ed 1, Revised. Toronto, Canada, CANMAT, 1999,
13. Patten SB, Sedmak B, Russell ML: Major depression: prevalence, treatment utilization and age in Canada. Can J Clin Pharmacol 2001; 8: 133-8.
14. Remick RA: Diagnosis and management of depression in primary care: a clinical update and review. CMAJ 2002; 167: 1253-60.
15. Department of National Defence and Canadian Forces: Canadian Forces Health and Lifestyle Information Survey 2000. Available at http://www.dnd.ca.
16. Worrall G, Ange J, Chaulk P, et al: Effectiveness of an educational strategy to improve family physicians' detection and management of depression: a randomised controlled trial. CMAJ 1999; 161: 37-40.
17. Grembowski DE, Martin D, Patrick DL, et al: Managed care, access to mental health specialists, and outcomes among primary care patients with depressive symptoms. J Gen Intern Med 2002; 17: 258-69.
18. U.S. Public Health Service: Mental Health: A Report of the Surgeon General. Washington, DC, U.S. Public Health Service, 2000. Available at http://www. surgeongeneral.gov/library/mentalhealth/home.html.
19. Kessler D, Lloyd K, Lewis G, Gray DPG: Cross-sectional study of symptom attribution and recognition of depression and anxiety in primary care. BMJ 1999; 318: 436-40.
20. Henderson S: The national survey of mental health and well-being in Australia: impact on policy. Can J Psychiatry 2002; 47: 819-24.
21. Davidon JRT: Recognition and treatment of posttraumatic stress disorder. JAMA 2001; 286: 584-8.
22. Ohayon MM, Lader MH: Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002; 63: 817-25.
23. Salerno SM, Browning R, Jackson JL: The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med 2002; 162: 19-24.
24. Punay NC, Couch JR: Antidepressants in the treatment of migraine headache. Curr Pain Headache Rep 2003; 7: 51-4.
25. Patten SB: Long-term medical conditions and major depression in the Canadian population. Can J Psychiatry 1999; 44: 151-7.